Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. Additionally, the financial results for the third quarter of 2023 include a charge of $1.1 million associated with the termination of our ATM program, and secondly, facility exit costs, which are aligned with our continuing efforts to improve operational efficiencies. These items have also been excluded from the discussion of our financial results. So now looking at the income statement, revenue was $125.3 million in the third quarter, down 2% compared to the prior quarter, and flat year-over-year. Activity associated with international upstream projects continue to expand, however, lower than expected activity in the U.S. and a lower level of product sales to international clients has offset the growth in other regions. Of this revenue, service revenue, which is more international, was $92.9 million for the quarter, flat sequentially, and up 6% from last year. Committed work volumes for traditional reservoir rock and fluid analysis, as well as carbon capture and storage projects, continue to build across our global laboratory network. However, revenue from our diagnostic services were down this quarter due to a decrease in U.S. onshore activity and some projects in the Gulf of Mexico moving from the third quarter into the fourth quarter. Additionally, service revenue associated with crude assay work was stable during the third quarter of this year, but down a little when compared to the third quarter of last year, which was elevated in our European operations ahead of the sanctions that became effective late last year. Product sales, which is more equally tied to the U.S. and international activity, were $32.5 million for the quarter, down 6% sequentially, and down 15% from last year. Despite the decrease in U.S. onshore activity during the third quarter of 2023, product sales in the U.S. were flat sequentially. The sequential decrease in our product sales in the third quarter is primarily associated with lower international product sales. The year-over-year decrease is due to lower sales in both the U.S. and international markets. Some international product sales scheduled to be delivered in the third quarter of 2023 were delivered in October. Additionally, in 2023, some recurring international product orders, which typically fall in the third quarter, are planned for the fourth quarter. Moving on to cost of services, ex-items for the quarter, was approximately 74% of service revenue, an improvement from 76% in the prior quarter and 77% compared to the prior year. We continue to see improvements in absorption of costs and utilization of our global laboratory network and anticipate additional improvement with continuous growth and service revenue. Cost of sales, ex-items in the third quarter, was 85% of revenue compared to 84% last quarter, which increased slightly this quarter due to reduced manufacturing efficiencies associated with lower international sales. G&A, ex-items for the quarter, was $9.5 million, a slight increase from prior quarter, which was $8.7 million. For 2023, we expect G&A, ex-items to be approximately $38 million to $39 million. Depreciation and amortization for the quarter was $3.9 million flat compared to last quarter. EBIT, ex-items for the quarter was $16 million, an increase of over 2% compared to last quarter, and yielding an EBIT margin of 13%, which expanded approximately 60 basis points sequentially. Year-over-year, EBIT, ex-items increased $2.7 million, or up 20%, and EBIT margins expanded 220 basis points. Our operating income for the quarter on a GAAP basis was $14.7 million. Interest expense of $3.1 million was relatively flat compared to $3.2 million last quarter. On September 30th of 2023, the company retired $75 million in senior notes, which carried a fixed interest rate of 4.1%. We used $71 million of the borrowing capacity under our bank credit facility to partially fund the maturity of these notes. The credit facility has a variable interest rate, and currently, the borrowing rate under the facility is approximately 8%. As such, we expect interest expense to increase approximately $600,000 next quarter. Income tax expense at an effective tax rate of 20% and ex-items was $2.6 million for the quarter. On a GAAP basis, tax expense was $2.3 million for the quarter, which was also at an effective tax rate of 20%. The effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe, and the impact of items discreet to each quarter. However, we continue to project the company's effective tax rate to be approximately 20%. Net income, ex-items for the quarter was $10.3 million, up from $9.8 million last quarter and $8.2 million from the same quarter last year. On a GAAP basis, we recorded net income of $9.3 million for the quarter. Earnings per diluted share, ex-items, was $0.22 for the quarter, up from $0.21 last quarter and up from $0.18 compared to the third quarter of last year. On a GAAP basis, earnings per diluted share was $0.19 for the quarter. Turning to the balance sheet, receivables was $104.1 million and decreased approximately $2.8 million from the prior quarter. Our DSOs for the third quarter improved slightly to 71 days from 72 days in the last quarter. Inventory was $75.1 million at the end of this quarter, up approximately $3.4 million from last quarter end. Inventory turns for the quarter decreased to $1.5 million from $1.7 million last quarter. The increase in inventory this quarter is the combined effect of a slowing U.S. land market, continued building of stock in certain international locations to service some long-term international contracts and some delays in delivery of bulk international sales, as I mentioned earlier. And now the liability side of the balance sheet. Our long-term debt was $181 million at September 30. In considering cash of $16.6 million, net debt was $164.4 million or up $5.6 million from last quarter. We remain focused on reducing debt and improving the leverage ratio of the company. Although, our leverage ratio increased slightly this quarter to 1.92, we have made considerable improvement from the leverage ratio of 2.29 at December 31, 2022. We will continue applying excess free cash towards the reduction of debt and anticipate the leverage ratio will decrease in future quarters. At the end of the quarter, we retired and fully settled the $75 million of 12-year senior notes that were issued in 2011. As I stated earlier, we use $71 million of the borrowing capacity under our bank revolving credit facility to partially fund the maturity of these notes. Therefore at September 30th, our debt is currently comprised of our senior notes at $110 million and with $71 million outstanding under our bank revolving credit facility. Our credit facility has a borrowing capacity of $135 million of which approximately $56 million was still available as of September 30, 2023. Looking at cash flow for the third quarter of 2023, cash flow used in operating activities was approximately $200,000 and after paying for $3.5 million of CapEx during the quarter, our free cash flow was negative $3.7 million. Cash from operations for the third quarter of 2023 was negatively affected by a build-in working capital of $14 million. The build-in working capital was primarily due to an increase in inventory and carrying a lower level of accounts payable at September 30th. The change in working capital also includes $11.3 million in cash tax payments during the quarter, which will partially be recovered in the fourth quarter. The company is expecting to receive approximately $7.1 million in tax refunds during the fourth quarter of 2023. Looking ahead to the fourth quarter, we are forecasting cash from operations to be much improved and positive with working capital remaining flat and additional cash in excess of $7 million associated with the tax refunds. We will continue to manage investment in working capital during a period of growth, and additionally, we expect CapEx to remain aligned with activity levels, and for the full year of 2023, we expect capital expenditures to be in the range of $11 million to $12 million. Core will continue its strict capital discipline and asset-like business model with capital expenditures primarily targeted at growth opportunities and initiatives. Core Lab’s operational leverage continues to provide the ability to grow revenue and profitability with minimal capital requirements. Capital expenditures have historically ranged from 2% to 4% of revenue, even during periods of significant growth. That same level of laboratory infrastructure, intellectual property, and leverage exists in the business today. I will now turn it over to Gwen for an update on our guidance and outlook.